Rockwell Medical (RMTI) Non-Current Assets (2010 - 2026)
Rockwell Medical (RMTI) posted Non-Current Assets of $20.5 million for Q1 2026, up 7.89% on a QoQ basis from $19.0 million in Q4 2025, and down 2.14% year-over-year from $20.9 million in Q1 2025.
Rockwell Medical (RMTI) Non-Current Assets (2010 - 2026) Analysis & Trends
Rockwell Medical's Non-Current Assets history runs 17 years deep, the most recent figure standing at $20.5 million for Q1 2026.
- Quarterly Non-Current Assets fell 2.14% year-over-year to $20.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.4 million (down 9.86% YoY) and the FY2025 annual result came in at $19.0 million, down 14.41% from the prior year.
- Non-Current Assets was $20.5 million for Q1 2026 at Rockwell Medical, up from $19.0 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $24.4 million in Q3 2023 and bottomed at $10.5 million in Q2 2023.
- A 5-year average of $18.3 million and a median of $20.5 million in 2026 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets retreated 14.76% — and 2024, when it surged 122.84%.
- Rockwell Medical's Non-Current Assets stood at $11.3 million in 2022, then surged by 106.65% to $23.4 million in 2023, then dropped by 5.23% to $22.2 million in 2024, then retreated by 14.41% to $19.0 million in 2025, then rose by 7.89% to $20.5 million in 2026.
- Business Quant data shows RMTI's Non-Current Assets at $20.5 million in Q1 2026, $19.0 million in Q4 2025, and $20.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 20.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.48 Mn |
| Dec 31, 2025 | 18.98 Mn |
| Sep 30, 2025 | 19.97 Mn |
| Jun 30, 2025 | 21.02 Mn |
| Mar 31, 2025 | 20.93 Mn |
| Dec 31, 2024 | 22.18 Mn |
| Sep 30, 2024 | 22.87 Mn |
| Jun 30, 2024 | 23.28 Mn |
| Mar 31, 2024 | 24.03 Mn |
| Dec 31, 2023 | 23.40 Mn |
| Sep 30, 2023 | 24.43 Mn |
| Jun 30, 2023 | 10.47 Mn |
| Mar 31, 2023 | 10.78 Mn |
| Dec 31, 2022 | 11.33 Mn |
| Sep 30, 2022 | 11.83 Mn |
| Jun 30, 2022 | 11.87 Mn |
| Mar 31, 2022 | 12.64 Mn |
| Dec 31, 2021 | 13.29 Mn |
| Sep 30, 2021 | 12.62 Mn |
| Jun 30, 2021 | 11.29 Mn |